Rchr
J-GLOBAL ID：201901018799303916   Update date: Sep. 07, 2024

Naito Sei

Naito Sei
Affiliation and department：
Yamagata University University Hospital Urology

About Yamagata University University Hospital Urology


Job title： Assistant Professor
Research field  (2)： Urology ,  Tumor biology
Research theme for competitive and other funds  (20)：
  • 2023 - 2026 Clinical application of cancer immunity-induced neutrophils and immunosuppressive neutrophils
  • 2022 - 2025 Metabolome analysis for identification of urothelial carcinoma metabotypes and exploration of diagnostic and therapeutic targets
  • 2022 - 2025 泌尿器癌に対する重粒子線治療における免疫学的効果予測因子の探求
  • 2019 - 2022 Exploration of novel therapeutic molecules for urothelial cancer based on the molecular subtypes and metabolomics
  • 2019 - 2022 Expression and function analysis of MDSC as a predictive factor of novel immunotherapy with GPI-80
Show all
Papers (228)：
  • Yuji Takeda, Tomoyuki Kato, Saima Sabrina, Sei Naito, Hiromi Ito, Naoto Emi, Yuya Kuboki, Yuki Takai, Hiroki Fukuhara, Masaki Ushijima, et al. Intracellular Major Histocompatibility Complex Class II and C-X-C Motif Chemokine Ligand 10-Expressing Neutrophils Indicate the State of Anti-Tumor Activity Induced by Bacillus Calmette-Guérin. Biomedicines. 2023. 11. 11
  • Shigemitsu Horie, Sei Naito, Shingo Hatakeyama, Shuya Kandori, Kazuyuki Numakura, Renpei Kato, Tomoyuki Koguchi, Shingo Myoen, Yoshihide Kawasaki, Akihiro Ito, et al. Preoperative prognostic model for localized and locally advanced renal cell carcinoma: Michinoku Japan Urological Cancer Study Group. International journal of clinical oncology. 2023
  • Renpei Kato, Sei Naito, Kazuyuki Numakura, Shingo Hatakeyama, Tomoyuki Koguchi, Takahiro Kojima, Yoshihide Kawasaki, Shuya Kandori, Sadafumi Kawamura, Yoichi Arai, et al. Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study. International journal of clinical oncology. 2023. 28. 5. 726-727
  • Hayato Nishida, Satoshi Takai, Hiromi Ito, Hiroki Fukuhara, Takaaki Nawano, Takafumi Narisawa, Hidenori Kanno, Mayu Yagi, Atsushi Yamagishi, Toshihiko Sakurai, et al. Anti-human leukocyte antigen and anti-ABO antibodies after SARS-CoV-2 mRNA vaccination in kidney transplant recipients. Clinical transplantation. 2023. e14952
  • Takafumi Narisawa, Sei Naito, Hiromi Ito, Osamu Ichiyanagi, Toshihiko Sakurai, Tomoyuki Kato, Norihiko Tsuchiya. Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinoma. BMC cancer. 2023. 23. 1. 170-170
ｍore...
MISC (150)：
ｍore...
Lectures and oral presentations  (53)：
  • 腎移植における尿中DPP4と移植腎Banff scoreの関連性についての検討
    (移植 2019)
  • Thiel法で固定した献体によるロボット支援下腎移植トレーニング
    (移植 2019)
  • 腎癌におけるFGFR4の発現と治療標的としての可能性について
    (腎癌研究会会報 2019)
  • 有転移腎癌症例に対する定期的頭部CT検査の有用性の検討
    (腎癌研究会会報 2019)
  • 精巣腫瘍に対する化学療法中に血栓症を発症した症例の検討
    (泌尿器外科 2019)
ｍore...
Education (2)：
  • 2007 - 2011 Yamagata University Graduate School, Division of Medical Sciences
  • - 2001 Yamagata University Faculty of Medicine
Work history (3)：
  • 2021/04 - 現在 Yamagata University Faculty of Medicine
  • 2008/04 - 2021/03 Yamagata University University Hospital Urology Assistant Professor
  • 2014/03 - 2015/06 Foxchase Cancer Center
Awards (1)：
  • 2011 - 山形大学医学部 山形大学医学部学術奨励賞銀賞
Association Membership(s) (12)：
日本癌学会 ,  日本癌治療学会 ,  日本泌尿器科学会 ,  ヨーロッパ泌尿器科学会 ,  日本泌尿器内視鏡外科学会 ,  JAPANESE SOCIETY OF ENDOUROLOGY ,  日本内視鏡外科学会 ,  Société Internationale d'Urologie ,  日本泌尿器腫瘍学会 ,  American Association of Cancer Research ,  European Association of Urology ,  American Urological Association
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM